Explore more topics
SEC Form 13F

SABBY MANAGEMENT, LLC 13F Holdings

Inspect SABBY MANAGEMENT, LLC's 2026-06-30 SEC 13F positions, public filing date, amendments and original receipt.

As of 2026-08-15T03:59:59.999Z

Report period
2026-06-30
Publicly available
2026-08-15
Reported value
$110,521,749
Positions
23
Jump to a section

Disclosed positions

Largest disclosed position values

Scale: 0 to 54,141,000 USD · zero baseline

Largest disclosed position values

  • STATE STREET SPDR S&P · ETF · Put+54,140,825 USD
  • STATE STREET SPDR S&P · ETF · Call+15,308,785 USD
  • ISHARES RUSSELL · ETF · Call+13,279,890 USD
  • ISHARES RUSSELL · ETF · Put+13,249,845 USD
  • SPY · ETF+4,107,235 USD
  • TOYO CO LTD · ORD+3,501,730 USD
  • ABIVAX SA · ADS · Call+1,092,732 USD
  • FARMMI INC · CL A+840,307 USD
  • SIDUS SPACE INC · CL A · Put+816,305 USD
  • CRVO · COM+771,528 USD

Reported underlying-position values for 2026-06-30, publicly available 2026-08-15. Put/call values are not option premiums; this subset is not a complete portfolio allocation. Exact issuer, class and unit remain in the table. Showing the first 10 of 23 recorded values; the complete table remains available below.

Inspect all 23 displayed rows: Disclosed positions

Scroll sideways to compare all columns. Select a heading to sort.

STATE STREET SPDR S&PUnresolvedETF$54,140,825725SHPut
STATE STREET SPDR S&PUnresolvedETF$15,308,785205SHCall
ISHARES RUSSELLUnresolvedETF$13,279,890442SHCall
ISHARES RUSSELLUnresolvedETF$13,249,845441SHPut
STATE STREET SPDR S&PSPYETF$4,107,2355,500SHNone
TOYO CO LTDUnresolvedORD$3,501,730503,846SHNone
ABIVAX SAUnresolvedADS$1,092,73282SHCall
FARMMI INCUnresolvedCL A$840,3073,515,929SHNone
SIDUS SPACE INCUnresolvedCL A$816,3052,905SHPut
CERVOMED INCCRVOCOM$771,528248,880SHNone
ZEVRA THERAPEUTICSUnresolvedCOM$612,318427SHPut
TEMPEST THERAPEUTICS INCTPSTCOM$567,527511,286SHNone
PARANOVUS ENTERTNMNT TECH LTUnresolvedCL A$560,51975,440SHNone
BIOAFFINITY TECHNOLOGIESUnresolvedCOM$296,905365,647SHNone
SMART POWER CORPCREGCOM$263,214127,774SHNone
BRIACELL THERAPEUTICS CORPBCTXCOM$261,53680,721SHNone
REVELATION BIOSCIENCES INCREVBCOM$216,899210,582SHNone
SENESTECH INCSNESCOM$211,216141,756SHNone
BRIACELL THERAPEUTICS CORPBCTXL*W$169,441190,383SHNone
SIDUS SPACE INCSIDUCL A$121,88943,377SHNone
INMED PHARMACEUTICALSINMCOM$69,70444,970SHNone
NUWELLIS INCNUWECOM$49,93516,372SHNone
BRIACELL THERAPEUTICS CORPBCTXZ*W$11,464120,802SHNone

Largest 50 positions by reported value; the filing may contain more positions.

Read one actual disclosure before using it

Show the table · 1 row, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

STATE STREET SPDR S&PUnresolvedETF$54,140,825725SHPut

First displayed source row from Disclosed positions. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-06-30 and its public availability date is 2026-08-15. Subtracting those calendar dates gives 46 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

Read the amount together with its Unit and Option columns. A reported put or call position is not an option premium paid, and a quarterly holding is not a purchase made on its public filing date. Check every accession in the effective amendment lineage below: a retained holding can originate in an earlier filing rather than the latest linked amendment.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

How amendments affect these holdings

This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 11 positions lack a resolved ticker and 7 positions are put or call entries.

The displayed holdings combine the effective filing versions listed here. The latest receipt linked below identifies the current projection version; it is not proof that every retained holding originated in that latest amendment. Inspect all effective accessions when verifying a position's source.

A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.

Show the table · 1 row, 2 columns
Effective SEC accessionRole in this view
0001104659-26-096397Latest effective version

Quarter end and public filing date

Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.